(Q40762702)

23 September 2017

title

Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate (English)

1 reference

23 September 2017

main subject

Paget's disease of bone

1 reference

O'Doherty DP

1

1 reference

23 September 2017

Bickerstaff DR

2

1 reference

23 September 2017

McCloskey EV

3

1 reference

23 September 2017

Hamdy NA

4

1 reference

23 September 2017

Beneton MN

5

1 reference

23 September 2017

Harris S

6

1 reference

23 September 2017

Mian M

7

1 reference

23 September 2017

Kanis JA

8

1 reference

23 September 2017

language of work or name

1 reference

1 May 1990

1 reference

Journal of Bone and Mineral Research

23 September 2017

published in

1 reference

23 September 2017

volume

5

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

483-491

1 reference

Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Structure-activity relationships of various bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Diphosphonate Therapy of Paget's Disease of Bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Paget's bloom of bone : Diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Determination of hydroxyproline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Nomogram for derivation of renal threshold phosphate concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Absorption of oral diphosphonate in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650050510

21 January 2018

Identifiers

DOI

10.1002/JBMR.5650050510

1 reference

23 September 2017

1 reference